A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body
Clinical trial NCT05568095 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05568095
- Sponsor
- Arcus Biosciences, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-21
- Primary completion
- 2026-08-01
- Enrollment
- 1040
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.